Anchor Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $893K | Buy |
8,314
+669
| +9% | +$71.9K | 0.08% | 197 |
|
|
2025
Q1 | $771K | Sell |
7,645
-493
| -6% | -$49.7K | 0.07% | 210 |
|
|
2024
Q4 | $727K | Buy |
8,138
+7,962
| +4,524% | +$711K | 0.07% | 215 |
|
|
2024
Q3 | $14.7K | Buy |
176
+46
| +35% | +$3.86K | ﹤0.01% | 732 |
|
|
2024
Q2 | $10K | Hold |
130
| – | – | ﹤0.01% | 750 |
|
|
2024
Q1 | $8.9K | Hold |
130
| – | – | ﹤0.01% | 802 |
|
|
2023
Q4 | $7.52K | Hold |
130
| – | – | ﹤0.01% | 787 |
|
|
2023
Q3 | $6.86K | Hold |
130
| – | – | ﹤0.01% | 800 |
|
|
2023
Q2 | $7.03K | Sell |
130
-120
| -48% | -$6.49K | ﹤0.01% | 787 |
|
|
2023
Q1 | $12.5K | Hold |
250
| – | – | ﹤0.01% | 711 |
|
|
2022
Q4 | $11.6K | Sell |
250
-91
| -27% | -$4.21K | ﹤0.01% | 699 |
|
|
2022
Q3 | $13.2K | Sell |
341
-2,464
| -88% | -$95.4K | ﹤0.01% | 685 |
|
|
2022
Q2 | $105K | Buy |
2,805
+2,555
| +1,022% | +$95.2K | 0.02% | 446 |
|
|
2022
Q1 | $11.1K | Hold |
250
| – | – | ﹤0.01% | 743 |
|
|
2021
Q4 | $10.6K | Hold |
250
| – | – | ﹤0.01% | 777 |
|
|
2021
Q3 | $10.8K | Hold |
250
| – | – | ﹤0.01% | 709 |
|
|
2021
Q2 | $10.7K | Hold |
250
| – | – | ﹤0.01% | 725 |
|
|
2021
Q1 | $9.66K | Hold |
250
| – | – | ﹤0.01% | 710 |
|
|
2020
Q4 | $8.99K | Hold |
250
| – | – | ﹤0.01% | 686 |
|
|
2020
Q3 | $9.55K | Buy |
250
+130
| +108% | +$4.97K | ﹤0.01% | 664 |
|
|
2020
Q2 | $4.21K | Hold |
120
| – | – | ﹤0.01% | 725 |
|
|
2020
Q1 | $3.92K | Buy |
+120
| New | +$3.92K | ﹤0.01% | 713 |
|